LINC01349

Across TCGA pan-cancer cohorts, LINC01349 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated LINC01349 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher LINC01349 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01349 expression acts as an unfavorable survival marker, although some lineages such as ACC and KIRC show a favorable association.

READ, ACC, and THYM are the cancer types where LINC01349 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Tertile	III,IV	0.111	0.903	<.001	63	view →
ACC	DFS	Quartile	All	0.926	0.562	<.001	48	view →
THYM	OS	Tertile	All	0.821	0.985	.009	45	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	36	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
COAD	OS	Tertile	II,III,IV	0.117	0.788	.001	27	view →
BRCA	OS	Tertile	II,III,IV	0.914	0.960	.007	24	view →
PAAD	OS	Tertile	II,III,IV	0.433	0.604	.026	18	view →
CHOL	OS	Tertile	All	0.089	0.673	.018	18	view →
SKCM	DFS	Tertile	IV	0.063	0.524	.003	18	view →
UVM	OS	Tertile	All	0.248	0.769	.007	18	view →
LGG	OS	Tertile	All	0.460	0.705	.009	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

LINC01349–READ (OS)

Open the READ breakdown →